Searching for an individualized EEG marker for predicting treatment outcome in PTSD
Completed
- Conditions
- PTSD en stress disorder10002861
- Registration Number
- NL-OMON41229
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 28
Inclusion Criteria
Patients:
- Patients with a diagnosis of chronic PTSD with symptom duration > 3 months
- CAPS score of * 45
- Male and female, aged 18 years and above
- Written informed consent
- Eligible for exposure therapy;Controls:
- Meeting the stressor A criterion of DSM-IV PTSD
- Male and female, aged 18 years and above
- Written informed consent
Exclusion Criteria
Patienten:
- Suicidal risk
- Presence of any of the following DSM IV diagnoses: psychotic disorder incl. schizophrenia, a bipolar disorder, depression with psychotic features, or excessive substance related disorder.
- Primary diagnosis of severe depressive disorder
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>We will first examine differences in the deviant-stimuli induced alpha<br /><br>suppression between PTSD and controls. We will then see how these differences<br /><br>in PTSD individuals relate to their treatment outcome.</p><br>
- Secondary Outcome Measures
Name Time Method <p>- </p><br>